Structures by: Jin Z.
Total: 136
C26H19ClO2
C26H19ClO2
Chemical Science (2020) 11, 46 12533-12539
a=9.0142(16)Å b=9.975(2)Å c=11.8175(14)Å
α=90.00° β=95.440(13)° γ=90.00°
C29H44O4
C29H44O4
Organic letters (2016) 18, 8 1772-1775
a=13.38314(17)Å b=6.24052(6)Å c=16.58575(16)Å
α=90° β=105.5835(12)° γ=90°
C19H17FeNO2
C19H17FeNO2
Organic letters (2017) 19, 20 5709-5712
a=9.4767(16)Å b=15.378(2)Å c=10.8957(19)Å
α=90.00° β=111.006(3)° γ=90.00°
C18H13FeNO3
C18H13FeNO3
Organic letters (2017) 19, 20 5709-5712
a=6.067(4)Å b=13.753(10)Å c=17.502(12)Å
α=90.00° β=99.914(9)° γ=90.00°
C19H17FeNO
C19H17FeNO
Organic letters (2017) 19, 20 5709-5712
a=19.945(4)Å b=8.3402(18)Å c=17.264(4)Å
α=90.00° β=91.165(5)° γ=90.00°
C18H21BrO4
C18H21BrO4
Organic letters (2010) 12, 22 5218-5221
a=9.9100(10)Å b=6.3413(6)Å c=28.512(3)Å
α=90.00° β=96.138(2)° γ=90.00°
C21H20BrNO4
C21H20BrNO4
Organic letters (2011) 13, 4 564-567
a=7.5957(13)Å b=11.494(2)Å c=21.526(4)Å
α=90.00° β=90.00° γ=90.00°
C26H21ClN2O2
C26H21ClN2O2
Chem. Sci. (2015) 6, 10 6008
a=9.5286(2)Å b=10.2653(3)Å c=21.7873(5)Å
α=90° β=90° γ=90°
C20H16BrNO5
C20H16BrNO5
Organic & biomolecular chemistry (2011) 9, 6 1809-1816
a=8.2259(12)Å b=12.3386(17)Å c=9.1136(13)Å
α=90.00° β=97.552(2)° γ=90.00°
C33H36Cl3N3NiO5
C33H36Cl3N3NiO5
Organic & biomolecular chemistry (2011) 9, 3 793-801
a=8.565(4)Å b=12.029(6)Å c=16.760(8)Å
α=90.00° β=91.239(10)° γ=90.00°
C14H14BrNO3
C14H14BrNO3
Organic & biomolecular chemistry (2010) 8, 20 4767-4774
a=6.607(3)Å b=10.212(4)Å c=20.641(8)Å
α=90.00° β=90.00° γ=90.00°
C21H22FO5P
C21H22FO5P
Chemical communications (Cambridge, England) (2018) 54, 47 6040-6043
a=8.7032(4)Å b=13.2565(6)Å c=18.0076(9)Å
α=90.00° β=90.00° γ=90.00°
C20H18FeO3
C20H18FeO3
Chemical communications (Cambridge, England) (2018) 54, 6 689-692
a=10.0132(2)Å b=10.02044(19)Å c=16.0394(3)Å
α=90.00° β=90.00° γ=90.00°
C32H28FeNO3PPd,3(CHCl3)
C32H28FeNO3PPd,3(CHCl3)
Chemical communications (Cambridge, England) (2018) 54, 6 689-692
a=11.649(2)Å b=12.431(3)Å c=15.066(3)Å
α=98.08(3)° β=104.26(3)° γ=105.36(3)°
C32H113ErGe2Mo22N8O100
C32H113ErGe2Mo22N8O100
New J. Chem. (2017)
a=13.1184(6)Å b=12.6369(5)Å c=32.3036(12)Å
α=90° β=96.168(4)° γ=90°
C32H111GdGe2Mo22N8O99
C32H111GdGe2Mo22N8O99
New J. Chem. (2017)
a=13.2175(3)Å b=12.7258(4)Å c=32.5224(10)Å
α=90° β=96.203(3)° γ=90°
C32H115DyGe2Mo22N8O101
C32H115DyGe2Mo22N8O101
New J. Chem. (2017)
a=13.2127(3)Å b=12.7291(3)Å c=32.5182(10)Å
α=90° β=96.158(2)° γ=90°
C32H113Ge2Mo22N8O100Tb
C32H113Ge2Mo22N8O100Tb
New J. Chem. (2017)
a=13.2174(6)Å b=12.7175(6)Å c=32.4095(14)Å
α=90° β=96.294(4)° γ=90°
MPHII
C10H11N2,I
Journal of Materials Chemistry A (2017) 5, 32 16976
a=8.2438(12)Å b=31.628(4)Å c=17.204(2)Å
α=90.00° β=93.388(2)° γ=90.00°
MT2II
C8H9IN2S
Journal of Materials Chemistry A (2017) 5, 32 16976
a=18.903(10)Å b=6.311(3)Å c=17.950(9)Å
α=90° β=90° γ=90°
MT3II
291.95
Journal of Materials Chemistry A (2017) 5, 32 16976
a=19.028(6)Å b=7.932(3)Å c=13.915(5)Å
α=90° β=90° γ=90°
C13H12BrNO3
C13H12BrNO3
Chemical Communications (2010) 46, 25 4589-4591
a=6.3371(16)Å b=11.773(3)Å c=17.660(5)Å
α=90.00° β=90.00° γ=90.00°
C14H13BrO3
C14H13BrO3
Chemical communications (Cambridge, England) (2010) 46, 32 5957-5959
a=6.5631(11)Å b=7.7659(12)Å c=27.286(4)Å
α=90.00° β=90.00° γ=90.00°
C56H34Cu2N6O14
C56H34Cu2N6O14
RSC Advances (2017) 7, 81 51658
a=12.1088(4)Å b=16.9597(8)Å c=19.1362(4)Å
α=111.443(4)° β=91.846(3)° γ=95.794(3)°
(E)-2-(4-(2-(9-octyl-9H-carbazol-3-yl)vinyl)phenyl)-3,3-diphenylacrylonitrile
C43H40N2
RSC Adv. (2016) 6, 39 32697
a=12.0380(6)Å b=14.1246(7)Å c=20.2492(10)Å
α=90° β=99.2470(10)° γ=90°
C21H21ClK3N3O28Ti3
C21H21ClK3N3O28Ti3
Dalton transactions (Cambridge, England : 2003) (2019) 48, 4 1175-1178
a=14.4378(16)Å b=21.135(2)Å c=11.9539(10)Å
α=90° β=98.084(3)° γ=90°
C50H26N4O14Zn3,O
C50H26N4O14Zn3,O
Dalton transactions (Cambridge, England : 2003) (2013) 42, 37 13335-13338
a=10.235(2)Å b=14.898(3)Å c=30.275(6)Å
α=90.00° β=101.897(6)° γ=90.00°
C14H9InN0O6
C14H9InN0O6
Chem.Commun. (2010) 46, 8612
a=19.2396(9)Å b=20.3017(9)Å c=46.143(2)Å
α=90.00° β=90.00° γ=90.00°
C22H22BrNO3
C22H22BrNO3
Chem.Commun. (2012) 48, 461
a=12.773(3)Å b=6.0463(13)Å c=13.400(3)Å
α=90.00° β=90.851(3)° γ=90.00°
C20H6Cl5N0O15Zn3
C20H6Cl5N0O15Zn3
Journal of Materials Chemistry (2010) 20, 19 3984
a=44.792(3)Å b=12.3416(7)Å c=20.7246(10)Å
α=90.00° β=114.539(2)° γ=90.00°
Lu2O7Si2
Lu2O7Si2
CrystEngComm (2010) 12, 5 1617
a=6.5621(9)Å b=6.5621(9)Å c=11.954(2)Å
α=90.00° β=90.00° γ=90.00°
Ir2
C48H50F8IrN4O5P
Dalton transactions (Cambridge, England : 2003) (2015) 45, 2 734-741
a=15.1089(4)Å b=11.0424(3)Å c=15.6517(4)Å
α=90.00° β=110.4110(10)° γ=90.00°
Bis(trimethylaminium) hexaaquazinc(II) bis(naphthalene-1,6-disulfonate)
2C6H16N^^,H12O6Zn2,2C10H6O6S22
Acta Crystallographica Section E (2005) 61, 7 m1363-m1365
a=7.0780(10)Å b=11.597(2)Å c=13.924(2)Å
α=77.890(10)° β=75.410(10)° γ=79.350(10)°
Diaqua(cyclohexane-1,1-diacetato-κ^2^O,O)(phenanthroline- κ^2^N,N')manganese(II) trihydrate
C22H26MnN2O6,3H2O
Acta Crystallographica Section E (2005) 61, 7 m1419-m1421
a=7.8763(3)Å b=25.0242(7)Å c=12.7232(3)Å
α=90° β=101.2750(10)° γ=90°
2-Amino-4-(ferrocenyl)-5-(1H-1,2,4-triazol-1-yl)-1,3-thiazole
C15H13FeN5S
Acta Crystallographica Section E (2005) 61, 7 m1269-m1271
a=7.507(5)Å b=20.018(14)Å c=9.600(7)Å
α=90.00° β=103.330(11)° γ=90.00°
Tetrakis(3,5-lutidine)dichloronickel(II)
C28H36Cl2N4Ni
Acta Crystallographica Section E (2005) 61, 5 m889-m891
a=11.5830(10)Å b=11.5830(10)Å c=10.7470(10)Å
α=90.00° β=90.00° γ=90.00°
5-(N,N-Dimethylammoniomethyl)-2,2-dimethyl-4-oxido-6-oxo-6H-1,3-dioxine
C9H15NO4
Acta Crystallographica Section E (2005) 61, 9 o3106-o3107
a=6.7922(5)Å b=8.4862(8)Å c=9.1518(8)Å
α=99.810(6)° β=101.532(3)° γ=92.919(5)°
Bis(piperazinium) di-μ-chloro-bis[diaquadichloromanganese(II)] dichloride
2C4H12N22,H4Cl6Mn2O22,2Cl
Acta Crystallographica Section E (2005) 61, 9 m1711-m1713
a=9.865(2)Å b=9.4290(10)Å c=13.506(2)Å
α=90.00° β=101.740(10)° γ=90.00°
[2-(4-nitrophenoxyl)-2-(1H-1,2,4-triazol-1-yl)acetyl]ferrocene
C20H16FeN4O4
Acta Crystallographica Section E (2005) 61, 9 m1837-m1839
a=9.863(2)Å b=10.081(2)Å c=10.731(3)Å
α=98.839(6)° β=95.787(5)° γ=114.928(7)°
C8H3Cl1O3
C8H3Cl1O3
Acta Crystallographica Section E (2004) 60, 2 o239-o240
a=6.929(2)Å b=7.8540(10)Å c=14.262(2)Å
α=77.690(10)° β=88.090(10)° γ=85.48(2)°
2-Amino-5-methylpyridinium phosphate
C6H9N2,H2PO4
Acta Crystallographica Section E (2005) 61, 7 o1983-o1984
a=7.9850(5)Å b=10.9104(6)Å c=11.1556(7)Å
α=90.00° β=108.414(2)° γ=90.00°
N-benzylidene-4-(ferrocenyl)-5-(1H-1,2,4-triazol-1-yl)-1,3-thiazol-2-amine
C22H17FeN5S
Acta Crystallographica Section E (2005) 61, 10 m2031-m2032
a=8.826(4)Å b=10.608(5)Å c=11.619(5)Å
α=64.982(7)° β=83.064(8)° γ=83.425(7)°
Tris(1,2-ethanediamine-N,N')nickel(II) dichloride dihydrate
C6H24N6Ni2,2Cl,2H2O
Acta Crystallographica Section E (2006) 62, 6 m1405-m1407
a=26.186(2)Å b=13.8917(9)Å c=12.8986(8)Å
α=90.00° β=93.197(2)° γ=90.00°
L-valinium chloride monohydrate
C5H12NO2,Cl,H2O
Acta Crystallographica Section E (2006) 62, 6 o2235-o2236
a=6.1550(10)Å b=6.8280(10)Å c=21.099(3)Å
α=90.00° β=90.00° γ=90.00°
Tetramethylpyrazinium--trichloroacetate--trichloroacetic acid (1/1/1)
C8H13N2,C2HCl3O2,C2Cl3O2
Acta Crystallographica Section E (2005) 61, 2 o419-o420
a=9.3627(12)Å b=9.6100(13)Å c=11.7698(15)Å
α=87.956(3)° β=72.496(2)° γ=79.561(2)°
Dicyclohexylaminium 4-hydroxysulfonate monohydrate
C12H24N,C6H5O4S,H2O
Acta Crystallographica Section E (2004) 60, 9 o1633-o1635
a=11.1091(4)Å b=11.7800(3)Å c=15.9282(5)Å
α=90.00° β=109.5630(10)° γ=90.00°
Tetramethylpyrazine--endo-norbornene-cis-5,6-dicarboxylic acid (1/2)
C9H10O4,0.5C8H12N2
Acta Crystallographica Section E (2005) 61, 3 o731-o732
a=6.106(2)Å b=9.293(3)Å c=11.580(4)Å
α=101.875(8)° β=97.890(6)° γ=98.590(8)°
Magnolol
2C18H18O2,C6H12N2
Acta Crystallographica Section E (2005) 61, 9 o2939-o2941
a=10.272(3)Å b=10.646(3)Å c=17.697(5)Å
α=103.948(5)° β=95.457(5)° γ=92.632(5)°
Hexaaquazinc(II) bis[trichloro(3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6- dione-κN^9^)zincate(II)] dihydrate
H12O6Zn2,2C8H10Cl3N4O2Zn,2H2O
Acta Crystallographica Section E (2005) 61, 9 m1849-m1851
a=8.8699(6)Å b=19.7245(13)Å c=10.8701(7)Å
α=90.00° β=111.5080(10)° γ=90.00°
N-[4-(N,N-Diethylamino)benzylidene]-4-phenyl- 5-(1H-1,2,4-triazol-1-yl)thiazol-2-amine
C22H22N6S
Acta Crystallographica Section E (2005) 61, 11 o3765-o3766
a=9.0753(16)Å b=20.924(4)Å c=11.518(2)Å
α=90.00° β=108.639(3)° γ=90.00°
Dicyclohexylammonium 1-(2-hydroxy-1-naphthyl)-2-naphtholate
C12H24N,C20H13O2
Acta Crystallographica Section E (2005) 61, 11 o3712-o3714
a=14.9935(11)Å b=10.1824(7)Å c=16.9848(12)Å
α=90.00° β=98.434(2)° γ=90.00°
Diaquadibenzimidazolebis(5-fluoro-2,4-dioxo-1,2,3,4-tetrahydropyrimidine- 1-acetato)cadmium(II)
C26H24CdF2N8O10
Acta Crystallographica Section E (2005) 61, 11 m2411-m2413
a=7.5216(5)Å b=8.3323(5)Å c=12.2228(7)Å
α=88.2870(10)° β=89.1140(10)° γ=68.0410(10)°
Diethylenetriammonium oxonium naphthalene-1,6-disulfonate 3.5-hydrate
C4H16N33,H3O,2C10H6O6S22,3.5H2O
Acta Crystallographica Section E (2005) 61, 12 o4325-o4327
a=25.392(2)Å b=13.1747(11)Å c=19.5144(16)Å
α=90.00° β=96.011(2)° γ=90.00°
Matrinium Tetrachloroferrate
C15H25N2O,Cl4Fe
Acta Crystallographica Section E (2005) 61, 12 m2466-m2468
a=8.4871(8)Å b=12.9037(12)Å c=18.2256(17)Å
α=90.00° β=90.00° γ=90.00°
Di-μ-chloro-bis[aqua(caffeine)chlorocopper(II)]
C16H24Cl4Cu2N8O6
Acta Crystallographica Section E (2005) 61, 12 m2631-m2633
a=9.761(2)Å b=12.891(3)Å c=10.901(2)Å
α=90.00° β=110.64(2)° γ=90.00°
Aquadichlorobis(2-chloropyridine-κN)copper(II)
C10H10Cl4CuN2O
Acta Crystallographica Section E (2005) 61, 12 m2566-m2567
a=14.005(3)Å b=15.339(3)Å c=6.4370(10)Å
α=90.00° β=90.00° γ=90.00°
Cichonidinium bis(perchlorate)
C19H24N2O2,2ClO4
Acta Crystallographica Section E (2006) 62, 7 o2614-o2616
a=6.5440(10)Å b=7.819(2)Å c=11.308(2)Å
α=88.67(2)° β=77.030(10)° γ=83.85(2)°
Bis(2,6-dimethylpyridinium) dichromate
2C7H10N,Cr2O72
Acta Crystallographica Section E (2006) 62, 1 m106-m108
a=13.600(3)Å b=8.3478(17)Å c=17.032(3)Å
α=90.00° β=113.10(3)° γ=90.00°
1-(1-Ferrocenyl-1-methoxy-3-phenylpropan-2-yl)-1H-1,2,4-triazole
C22H23FeN3O
Acta Crystallographica Section E (2004) 60, 11 m1692-m1694
a=10.165(5)Å b=14.205(7)Å c=13.262(6)Å
α=90.00° β=90.00° γ=90.00°
Urotropine--2,2,3,3-tetramethylcyclopropanecarboxylic acid (1/1)
C8H14O2,C6H12N4
Acta Crystallographica Section E (2006) 62, 7 o3122-o3123
a=10.2439(14)Å b=7.0715(9)Å c=42.491(6)Å
α=90.00° β=96.881(2)° γ=90.00°
(Z)-3-(2,6-Dichlorophenyl)-1-(pyridin-3-yl)-2-(1H-1,2,4-triazol-1-yl)prop- 2-en-1-one
C16H10Cl2N4O
Acta Crystallographica Section E (2005) 61, 11 o3599-o3601
a=8.0749(14)Å b=19.795(3)Å c=10.1321(17)Å
α=90.00° β=98.280(2)° γ=90.00°
2-Amino-4-(2,5-dichlorophenyl)-5-(1H-1,2,4-triazol-1-yl)-1,3-thiazole
C11H7Cl2N5S
Acta Crystallographica Section E (2004) 60, 12 o2517-o2519
a=7.842(2)Å b=11.324(3)Å c=14.840(4)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethyl-l-phenylalaninol bromide triydrate
C12H20NO,Br,1.5H2O
Acta Crystallographica Section E (2005) 61, 1 o72-o74
a=13.2146(17)Å b=6.9739(9)Å c=16.210(2)Å
α=90.00° β=91.490(2)° γ=90.00°
2-(2,3-dimethylphenoxy)-1-(pyridin-2-yl)-2-(1H-1,2,4-triazol-1-yl)ethanone
C17H16N4O2
Acta Crystallographica Section E (2005) 61, 10 o3466-o3467
a=7.700(2)Å b=9.989(3)Å c=11.230(3)Å
α=102.490(4)° β=108.484(4)° γ=97.688(4)°
[2-Hydroxy-1,1-bis(hydroxymethyl)ethyl]bis(2-hydroxyethyl)ammonium 4-nitrobenzoate monohydrate
C8H20NO5,C7H4NO4,H2O
Acta Crystallographica Section E (2006) 62, 4 o1276-o1278
a=6.5419(6)Å b=11.5935(10)Å c=13.4632(12)Å
α=67.290(2)° β=77.302(2)° γ=82.612(2)°
Matrinium picrolonate 0.28-hydrate
C15H25N2O,C10H7N4O5,0.28H2O
Acta Crystallographica Section E (2006) 62, 10 o4270-o4271
a=8.3939(7)Å b=14.9227(13)Å c=10.0939(9)Å
α=90.00° β=92.166(2)° γ=90.00°
Bis(2-amino-6-methylpyridinium) di-μ-chlorido-μ-oxido-bis[dichloridoantimonate(III)]
2C6H9N2,Cl6OSb22
Acta Crystallographica Section E (2007) 63, 7 m1786-m1787
a=10.0746(10)Å b=15.1972(16)Å c=15.4631(14)Å
α=90.00° β=101.597(6)° γ=90.00°
2-Amino-6-methylpyridinium Ferulate
C6H9N2,C10H9O4,H2O
Acta Crystallographica Section E (2007) 63, 9 o3866-o3866
a=11.266(2)Å b=9.7110(10)Å c=15.024(2)Å
α=90.00° β=104.547(8)° γ=90.00°
1-(carboxymethyl)-5-fluorouracil
C6H5FN2O4
Acta Crystallographica Section E (2007) 63, 11 o4214-o4214
a=6.809(4)Å b=4.840(3)Å c=11.946(7)Å
α=90.00° β=92.218(9)° γ=90.00°
(E)-1-[2,6-Dichloro-4-(trifluoromethyl)phenyl]-5-\ [(dimethylamino)methyleneamino]-1H-pyrazole-4-carboxylic acid
C14H11Cl2F3N4O2
Acta Crystallographica Section E (2007) 63, 12 o4562-o4562
a=16.4987(15)Å b=17.5642(16)Å c=11.8035(11)Å
α=90.00° β=95.626(2)° γ=90.00°
7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6(1H,3H)-dione trichloroacetic acid solvate
C11H14N4O4,C2HCl3O2
Acta Crystallographica Section E (2008) 64, 1 o347-o347
a=5.656(3)Å b=10.825(5)Å c=14.962(7)Å
α=93.217(9)° β=91.090(8)° γ=101.725(9)°
Ethylenediammonium bis(p-methylbenzenesulfonate) monohydrate
C2H10N22,2(C7H7O3S),H2O
Acta Crystallographica Section E (2008) 64, 1 o346-o346
a=11.302(2)Å b=7.7240(10)Å c=12.648(2)Å
α=90.00° β=111.770(10)° γ=90.00°
2-(4-Methylphenylsulfonamido)acetic acid
C9H11NO4S
Acta Crystallographica Section E (2007) 63, 9 o3719-o3719
a=22.3240(19)Å b=5.7263(5)Å c=16.5526(14)Å
α=90.00° β=109.069(2)° γ=90.00°
Bis(4-methylpyridinium) pentachloridoantimonate(III)
2C6H8N,Cl5Sb2
Acta Crystallographica Section E (2007) 63, 9 m2375-m2375
a=8.9815(13)Å b=10.4501(16)Å c=10.7488(16)Å
α=97.639(2)° β=110.180(3)° γ=98.242(2)°
Bis(dimethyloxonium) pentachloridoantimonate(III)
2C2H7O,SbCl52
Acta Crystallographica Section E (2007) 63, 9 m2411-m2411
a=8.5731(15)Å b=11.858(2)Å c=14.899(3)Å
α=90.00° β=90.00° γ=90.00°
Doxofyllinium tetrachloridoantimonate(III) monohydrate
C11H15N4O4,Cl4Sb,H2O
Acta Crystallographica Section E (2008) 64, 1 m167-m167
a=8.9783(5)Å b=10.4727(5)Å c=11.0357(4)Å
α=68.7550(10)° β=82.671(2)° γ=88.228(2)°
7-(1,3-Dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione
C11H14N4O4
Acta Crystallographica Section E (2007) 63, 2 o726-o727
a=4.9163(15)Å b=20.753(6)Å c=11.772(4)Å
α=90.00° β=91.063(6)° γ=90.00°
Cinchonidinium bis(4-methylbenzenesulfonate) monohydrate
C19H24N2O2,2C7H7SO3,H2O
Acta Crystallographica Section E (2006) 62, 8 o3398-o3400
a=6.565(3)Å b=9.599(4)Å c=12.748(5)Å
α=85.25(3)° β=84.08(3)° γ=82.71(3)°
(-)-(2R,3R)-O,O'-Dibenzoyl-(2R,3R)-tartaric acid--hexamethylphosphoramide (1/2)
C18H14O8,2(C6H18N3OP)
Acta Crystallographica Section E (2007) 63, 4 o1546-o1548
a=12.2940(2)Å b=19.1370(3)Å c=32.5842(6)Å
α=90.00° β=90.00° γ=90.00°
Ammonium 4-hydroxybenzenesulfonate
H4N,C6H5O4S
Acta Crystallographica Section E (2007) 63, 8 o3481-o3481
a=10.227(2)Å b=7.1414(13)Å c=11.461(2)Å
α=90.00° β=100.163(4)° γ=90.00°
Doxofylline--acrylic acid (1/1)
C11H14N4O4,C3H4O2
Acta Crystallographica Section E (2007) 63, 8 o3609-o3609
a=5.5365(6)Å b=10.1199(12)Å c=14.2916(16)Å
α=87.182(2)° β=88.023(2)° γ=80.578(2)°
Ammonium trichloro(hexamethylenetetramine)zincate 1.5-hydrate
NH4,C6H12Cl3N4Zn,1.5(H2O)
Acta Crystallographica Section E (2006) 62, 12 m3591-m3593
a=8.7692(19)Å b=9.621(2)Å c=17.137(4)Å
α=90.00° β=94.842(4)° γ=90.00°
Dichloro(N,N,N',N'-tetramethylethylenediamine)zinc(II)
C6H16Cl2N2Zn
Acta Crystallographica Section E (2006) 62, 12 m3174-m3175
a=7.6017(2)Å b=13.2521(4)Å c=11.3396(3)Å
α=90.00° β=103.8730(10)° γ=90.00°
Cinchoninium 3-Carboxybenzoate
C19H23N2O,C8H5O4
Acta Crystallographica Section E (2006) 62, 12 o5791-o5793
a=8.5208(6)Å b=10.2582(8)Å c=26.8066(18)Å
α=90.00° β=90.00° γ=90.00°
Dichlorido(hexamethylphosphamide)(morpholine-κN)copper(II)
C10H27Cl2CuN4O2P
Acta Crystallographica Section E (2007) 63, 5 m1473-m1475
a=8.2649(3)Å b=9.7300(3)Å c=12.0927(3)Å
α=86.1500(10)° β=81.8210(10)° γ=67.9100(10)°
7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione acetic acid solvate
C11H14N4O4,C2H4O2
Acta Crystallographica Section E (2007) 63, 5 o2676-o2677
a=5.3724(11)Å b=18.223(4)Å c=7.6663(16)Å
α=90.00° β=100.474(4)° γ=90.00°
Benzene-1,3-dicarboxylic acid--4-methylpyridine (1/2)
C8H6O4,2C6H7N
Acta Crystallographica Section C (2005) 61, 10 o593-o595
a=6.863(6)Å b=39.81(3)Å c=13.527(11)Å
α=90.00° β=93.276(15)° γ=90.00°
Bis(thiocarbohydrazide)thiocyanatoiron(II)
C4H12FeN10S4
Acta Crystallographica Section C (2005) 61, 6 m311-m312
a=5.2176(6)Å b=8.0061(9)Å c=8.7683(10)Å
α=78.662(2)° β=84.150(2)° γ=88.891(2)°
2-Amino-5-methylpyridinium (2-amino-5-methylpyridine)trichlorozincate(II)
C6H9N2,C6H8N2ZnCl3
Acta Crystallographica Section C (2005) 61, 4 m197-m199
a=9.254(3)Å b=13.726(4)Å c=13.572(5)Å
α=90.00° β=102.57(3)° γ=90.00°
Bis(2-amino-6-methylpyridinium) tetrachlorozincate(II)
2C6H9N2,Cl4Zn2
Acta Crystallographica Section C (2005) 61, 1 m43-m45
a=7.6642(8)Å b=7.9235(8)Å c=15.6651(16)Å
α=81.177(2)° β=79.128(2)° γ=89.983(2)°
(Acetato-κ^2^<i>O</i>,<i>O</i>)bis(1,10-phenanthroline- κ^2^<i>N</i>,<i>N</i>')copper(II) trifluoroacetate tetrahydrate
C26H19CuF3N4O2,C2F3O2,4(H2O)
Acta Crystallographica Section E (2010) 66, 7 m865
a=8.9019(7)Å b=11.6662(9)Å c=15.6980(10)Å
α=101.6190(10)° β=101.5120(10)° γ=108.5140(10)°
C23H24
C23H24
Chemistry of Materials (2019) 31, 5 1767
a=5.5751(4)Å b=25.0978(18)Å c=12.0481(8)Å
α=90° β=91.294(3)° γ=90°
H3.42B1.50NaO7.96PV0.50
H3.42B1.50NaO7.96PV0.50
Chemistry of Materials (2008) 20, 15 4900
a=20.1007(7)Å b=20.1007(7)Å c=20.1007(7)Å
α=90.00° β=90.00° γ=90.00°
C10H19Al6N4O28P7
C10H19Al6N4O28P7
Chemistry of Materials (2008) 20, 13 4179
a=9.0150(5)Å b=9.4739(6)Å c=19.7373(11)Å
α=88.9640(10)° β=78.9380(10)° γ=85.4890(10)°
C26H17F3N2O4S
C26H17F3N2O4S
ACS Catalysis (2019) 10971
a=9.9025(7)Å b=8.5425(5)Å c=26.6115(16)Å
α=90° β=97.442(2)° γ=90°
C24H16N2O3
C24H16N2O3
ACS Catalysis (2019) 10971
a=9.2224(2)Å b=8.9700(2)Å c=11.9200(3)Å
α=90° β=112.4768(9)° γ=90°
C18H12N2O5S
C18H12N2O5S
ACS Catalysis (2019) 10971
a=8.4139(8)Å b=8.7598(11)Å c=11.5432(14)Å
α=104.951(6)° β=108.859(7)° γ=96.299(5)°
C17H15NO5
C17H15NO5
ACS Catalysis (2018) 8, 9 8810
a=21.4471(10)Å b=6.4084(3)Å c=12.0690(5)Å
α=90° β=113.464(2)° γ=90°
C19H17BrO3
C19H17BrO3
ACS Catalysis (2018) 8, 9 8810
a=8.8312(4)Å b=11.2095(6)Å c=16.7904(9)Å
α=90° β=90° γ=90°
C28H26N4O7
C28H26N4O7
ACS Catalysis (2018) 8, 10 9859
a=9.0462(4)Å b=11.8256(5)Å c=23.9232(9)Å
α=90° β=90° γ=90°